Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Reggio Calabria
Clinical trial register · Italy

Clinical Trials in Reggio Calabria, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 2855 Bologna 1282 Roma 1266 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Geron Corporation2 Italfarmaco2 Bristol-Myers Squibb2 Swedish Orphan Biovitrum1 Xenon Pharmaceuticals Inc.1 Fondazione Italiana Linfomi - ETS1 Takeda1 University Hospital of Ferrara1 Hoffmann-La Roche1 Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 Alexion Pharmaceuticals, Inc.1 Kite, A Gilead Company1 Ciceri Fabio1 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1 AbbVie1 AstraZeneca1 Priothera SAS1 BioLineRx, Ltd.1 IRCCS Azienda Ospedaliero-Universitaria di Bologna1 Centro Cardiologico Monzino1 RECORDATI GROUP1 GCP-Service International West GmbH1 Celgene1
Site location
Milan2855 Bologna1282 Roma1266 Naples983 Rome968 Florence788 Pavia573 Brescia523 Padova504 Genova490 Rozzano473 Bari451 Pisa401 Bergamo378 Meldola355 Catania340 Ancona298 Monza281 Verona281 Palermo277 Torino275 Modena259 Aviano201 Messina167 Alessandria164 Show all 490
All 490 locations
Target enrolment
to

Trials with a site in Reggio Calabria

26 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy
NCT07463781Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS
Observational
100
Alessandria, Ancona, Brescia, Palermo, Reggio Calabria, Roma, Taranto, Udine
2026-05
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
100
Rome, Catania, Catanzaro, Reggio Calabria
2025-09-01
Recruiting
Takeda
Phase 3
225
Ancona, Turin, Florence, Milan, Pavia, Reggio Calabria, Rome, Rozzano
2025-05-06
Recruiting
Ciceri Fabio
Observational
80
Reggio Calabria, Milan
2025-02-22
Recruiting
Exercise Activity to Improve Mobility in Patients With CKD and PAD
NCT06621264Chronic Kidney Disease Stage 3 and 4, Peripheral Artery Disease (PAD)
University Hospital of Ferrara
Not applicable
124
Ferrara, Peschiera del Garda, Reggio Calabria
2024-10-01
Active, closed
GCP-Service International West GmbH
Phase 2
41
Ancona, Bari, Candiolo, Florence, Milan, Reggio Calabria
2024-09-10
Recruiting
Italfarmaco
Phase 3
220
Bari, Reggio Calabria, Bologna, Meldola, Reggio Emilia, Udine, Rome, Bergamo
2024-03-26
Active, closed
Bristol-Myers Squibb
Phase 3
402
Rome, Milan, Rozzano, Turin, Florence, Bologna, Reggio Calabria, Roma
2023-10-24
Active, closed
Bristol-Myers Squibb
Phase 3
106
Reggio Calabria, Naples, Rome, Pavia, Rozzano (MI), Novara, Turin, Florence
2023-10-05
Active, closed
Swedish Orphan Biovitrum
Observational
165
Bari, Bassano del Grappa, Bologna, Cagliari, Florence, Milan, Novara, Reggio Calabria
2023-06-26
Active, closed
Kite, A Gilead Company
Phase 3
300
Bologna, Brescia, Milan, Perugia, Reggio Calabria, Rome, Rozzano
2023-02-10
Active, closed
Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia
NCT07232953Acute Myeloid Leukaemia (AML), Hematopoietic Stem Cell Transplant (HSCT)
DrugsTreosulfan·Fludarabine
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 2
82
Reggio Calabria, Naples, Modena, Udine, Brescia, Milan, Cuneo, Ancona
2022-11-10
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
80
Avellino, Bassano del Grappa, Florence, Milan, Reggio Calabria, Roma
2022-10-28
Recruiting
Priothera SAS
Phase 3
366
Reggio Calabria, San Giovanni Rotondo, Alessandria, Ascoli Piceno, Brindisi, Florence, Lecce, Milan
2022-06-16
Active, closed
Centro Cardiologico Monzino
Not applicable
27,520
Scafa, Martano, Reggio Calabria, Benevento, Salerno, Carpi, Pradamano, Pozzilli
2022-06-10
Recruiting
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
NCT06516406Myelofibrosis, Primary Myelofibrosis, Secondary Myelofibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,055
Cosenza, Reggio Calabria, Naples, Bologna, Ferrara, Parma, Piacenza, Ravenna
2022-05-06
Active, closed
Hoffmann-La Roche
Observational
800
Taranto, Reggio Calabria, Meldola, Rome, Genoa, Brescia, Cremona, Novara
2021-05-10
Active, closed
Geron Corporation
Phase 3
327
Alessandria, Bologna, Cona, Florence, Genova, Milan, Ravenna, Reggio Calabria
2021-04-12
Active, closed
AbbVie
Phase 3
531
Rozzano, Naples, Rome, Bologna, Reggio Calabria
2020-09-10
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Brescia, Campobasso, Novara, Palermo, Pavia, Ravenna, Reggio Calabria, Roma
2019-12-12
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Bologna, Catanzaro, Milan, Pavia, Pisa, Reggio Calabria, Roma
2019-01-30
Active, closed
AstraZeneca
Phase 3
1,407
Brescia, Lecce, Lecco, Milan, Mirano, Naples, Reggio Calabria, Reggio Emilia
2019-01-04
Active, closed
Celgene
Phase 3
363
Orbassano, Bologna, Florence, Meldola, Milan, Padova, Reggio Calabria, Roma
2019-01-02
Active, closed
BioLineRx, Ltd.
Phase 3
180
Catania, Reggio Calabria
2018-03-23
Active, closed
Geron Corporation
Phase 2/3
289
Milan, Rozzano, Rionero in Vulture, Roma, Ancona, Bologna, Florence, Reggio Calabria
2016-01-12
Active, closed
Italfarmaco
Phase 2
90
Bari, Bergamo, Florence, Milan, Pescara, Pavia, Reggio Calabria, Vicenza
2013-03
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-italy/city/reggio-calabria

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Reggio Calabria.

How many clinical trials are recruiting in Reggio Calabria?

6 of the 26 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 18 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Reggio Calabria), 26 studies
PhaseStudiesRecruitingShare
Phase 312346.2%
Observational7226.9%
Phase 24015.4%
Not applicable217.7%
Phase 2/3103.8%

Most active sponsors

Lead sponsors with the most studies (Reggio Calabria)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb20
Geron Corporation20
Italfarmaco21
AbbVie10
Alexion Pharmaceuticals, Inc.10
AstraZeneca10
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia10
BioLineRx, Ltd.10
Celgene10
Centro Cardiologico Monzino10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.